- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Virtual Event – Current Guidelines & Unmet Needs In The Treatment of Agitation Associated With Alzheimer’s Dementia
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Current Guidelines & Unmet Needs In The Treatment of Agitation Associated With Alzheimer’s Dementia
This is a Virtual Event for PsychU members in Illinois, Iowa, Kansas, Minnesota, Missouri, North Dakota, South Dakota, and Wisconsin.
Individualized and multimodal treatment plans are recommended for patients with Alzheimer’s disease and Agitation associated with Alzheimer’s Dementia (AAD). There is a need for better identification of AAD. There is also a need for approved pharmacological treatments that have proven and favorable benefit, risk profiles to reduce symptoms and ultimately improve burden to caregivers and healthcare.
In this discussion, current treatment guidelines, assess risk/benefit profile, and discuss unmet needs of AAD treatment will be reviewed.
Featuring
Maria Perez, PharmD, AAHIVP
Medical Science Liaison – Digital Therapeutics
Heather Fields, PharmD, MPH, BCACP (OPDC)
Medical Science Liaison
Speakers Maria Perez, PharmD, AAHIVP and Heather Fields, PharmD, MPH, BCACP are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
-
Virtual Event – Addressing Unresolved Symptoms of Major Depressive Disorder
December 5 12:00 pm to 1:00 pm -
Virtual Event – Unmet Needs in Agitation Associated with Dementia Due to Alzheimer’s Disease
December 10 3:00 pm to 4:00 pm -
Virtual Event – Strategies to Optimize Patient Outcomes in Bipolar I Disorder
December 11 1:00 pm to 3:00 pm
Registration
Related Resources
-
Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)
On-Demand Webinar December 3, 2025In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.
-
Myths & Misconceptions: Bipolar Disorder
Podcast November 10, 2025Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.
-
Understanding the Complexity of Attention-Deficit Hyperactivity Disorder
On-Demand Webinar October 16, 2025Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected:


